Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Prostate cancer has significant mortality and metastasis rate in the male. Unfortunately, effective treatment for patients with advanced prostate cancer is still lacking. Verbascoside, a phenylethanoid glycoside, displays various pharmacological properties, such as the anti‐cancer activities. The present study aimed to evaluate the effects of purified verbascoside on human prostate cancer and the associated molecular mechanisms.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>The human prostate cancer cell lines, Du‐145 and PC‐3, were treated with various concentrations of verbascoside (0.1, 1, 10 μM) for 24 h followed by the examination of cell viability using MTT and trypan blue exclusion assays. Cell migration and invasion capacities were assessed by wound healing assay and transwell system. Western blot and immunofluorescence staining were used to detect the expression of epithelial‐mesenchymal transition (EMT)‐associated factors, components of transforming growth factor (TGF‐β)/Smad signaling, and high‐mobility group box (HMGB)/receptor for advanced glycation end‐products (RAGE) axis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Verbascoside treatment significantly inhibited cell proliferation, migration, and invasion abilities of Du‐145 and PC‐3 cells. We showed that verbascoside decreased the expression of EMT promotors, Snail and Slug, and increased the expression of E‐cadherin. Moreover, the expression level of alpha‐smooth muscle actin was downregulated by verbascoside as well. Besides, we found that the TGF‐β pathway was suppressed, which was demonstrated by the diminished expression of type I and II TGF‐β receptors and phosphorylated Smad2/3 along with the upregulated Smad7. Our data suggested that this downregulation of TGF‐β signaling was mediated by repression of HMGB 1 (HMGB1)/RAGE axis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Verbascoside mitigated the cell proliferation and aggressiveness of prostate cancer via downregulation of TGF‐β‐associated EMT progression through HMGB1/RAGE suppression. Collectively, our findings revealed that verbascoside may be a beneficial dietary supplement for prostate cancer patients.</p></section>

Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-Met-mediated epithelial-mesenchymal transition.

Verbascoside inhibits progression of glioblastoma cells by promoting Let‐7g‐5p and down‐regulating HMGA2 via Wnt/beta‐catenin signalling blockade

Tumor-derived Exosomal Microrna-7-5p Enhanced by Verbascoside Inhibits Biological Behaviors of Glioblastoma in Vitro and in Vivo

Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation

Molecular mechanism of verbascoside in the treatment of glioblastoma by inhibiting STAT3 phosphorylation by upregulating SHP-1 expression

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling

Anti-VEGFR2 Monoclonal Antibody(msb0254) Inhibits Angiogenesis and Tumor Growth by Blocking the Signaling Pathway Mediated by VEGFR2 in Glioblastoma.

Cyclovirobuxine D Inhibits Cell Proliferation and Migration and Induces Apoptosis in Human Glioblastoma Multiforme and Low-Grade Glioma

c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.

Cyclopeptide moroidin inhibits vasculogenic mimicry formed by glioblastoma cells via regulating β-catenin activation and EMT pathways

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/ TGF ‐β pathway

Metformin Inhibits TGF-β1-induced Epithelial-to-mesenchymal Transition-Like Process and Stem-Like Properties in GBM Via AKT/mTOR/ZEB1 Pathway

Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)

Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma

Effect of Verbascoside on Apoptosis and Metastasis in Human Oral Squamous Cell Carcinoma.

Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.

A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.

Modulation of Autophagy is a Potential Strategy for Enhancing the Anti-Tumor Effect of Mebendazole in Glioblastoma Cells

Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells

Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression

RBMS3-induced circHECTD1 encoded a novel protein to suppress the vasculogenic mimicry formation in glioblastoma multiforme